Clinical Trial Update: A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

View source ↗

Summary

A completed clinical trial update describing a study in pulmonary arterial hypertension comparing macitentan versus selexipag.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan (macitentan)
• Selexipag (selexipag)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED